J&J combines consumer groups; Bill Gates extends vax distribution;

> McNeil has assumed full ownership of the Johnson & Johnson($JNJ)-Merck Consumer Pharmaceuticals Co. joint venture. Release

> Bill Gates is taking on the cold chain with his Global Alliance for Vaccines and Immunizations organization, providing funding for delivering rotavirus vaccine to 16 additional developing countries and pneumococcus vaccine to 18 more countries. News

> Pharma companies want lower prices, says SAFC president Gilles Cottier, but suppliers can only offer them with greater commitment on chemical volumes. Item

> Eight Vietnamese pharma companies have complained to anti-corruption officials about the chief of the Vietnam Drug Administration, Truong Quoc Cuong, charging favoritism in granting medicine and drug import licenses. Story

> CMC Biologics, a Danish development and manufacturing service provider, has unveiled a $10 million addition to its cellular manufacturing plant that gives it the capacity to enter commercial production. Article

> Australians got a sense of the tone and style of FDA inspection reports through selections run in The Australian after agency visits to Aussie vax maker CSL. Report

> The FDA has conducted a review of diversion and counterfeit criminal case information. Summary

> UPS ($UPS) says it will offer PharmaPort 360, which will provide "near real-time monitoring and maintaining product temperatures in extreme outside conditions." Release

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.